Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun 26:5:4240.
doi: 10.1038/ncomms5240.

Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR-Cas platform

Affiliations
Free PMC article

Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR-Cas platform

K Yoshimi et al. Nat Commun. .
Free PMC article

Abstract

The bacterial CRISPR/Cas system has proven to be an efficient gene-targeting tool in various organisms. Here we employ CRISPR/Cas for accurate and efficient genome editing in rats. The synthetic chimeric guide RNAs (gRNAs) discriminate a single-nucleotide polymorphism (SNP) difference in rat embryonic fibroblasts, allowing allele-specific genome editing of the dominant phenotype in (F344 × DA)F1 hybrid embryos. Interestingly, the targeted allele, initially assessed by the allele-specific gRNA, is repaired by an interallelic gene conversion between homologous chromosomes. Using single-stranded oligodeoxynucleotides, we recover three recessive phenotypes: the albino phenotype by SNP exchange; the non-agouti phenotype by integration of a 19-bp DNA fragment; and the hooded phenotype by eliminating a 7,098-bp insertional DNA fragment, evolutionary-derived from an endogenous retrovirus. Successful in vivo application of the CRISPR/Cas system confirms its importance as a genetic engineering tool for creating animal models of human diseases and its potential use in gene therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1. NHEJ-mediated KO and HDR-mediated KI in Wistar rats using the CRISPR/Cas system.
(a) Schematic representation of the rat tyrosinase (Tyr) gene. The magnified view illustrates the gRNA binding sites (blue) and the PAM sequences (green). Wistar albino rats carry a G896A SNP mutation (orange) in exon 2 of the Tyr gene. (b) Plasmids expressing gRNA and codon-optimized Cas9 were transfected into Wistar-derived Rat-1 fibroblasts. The Surveyor (Cel-I) nuclease assay on exon 2 of Tyr showed targeted cleavage of the digested PCR products (indicated by arrowheads). M: DNA marker phiX174-HaeIII digest. Cas9: Cas9-transfected Rat-1. Cas9 gRNA: Cas9 and gRNA plasmid -transfected Rat-1. (c) Microinjection of gRNA and Cas9 mRNA into fertilized Wistar rat eggs. Sequence analysis of PCR products amplified from the genomic DNA of two-cell embryos showed a wide variety of indel mutations mediated by NHEJ at the targeted Tyr exon 2 (see also Table 1). (d) Co-injection of gRNA, Cas9 mRNA, and ssODN into fertilized Wistar rat eggs. Sequence analysis showed indel mutations at the targeted Tyr exon 2 as well as the precise SNP exchange mediated by HDR that resulted in KI alleles (see also Table 1).
Figure 2
Figure 2. Allele-specific genome editing in F1 rats by the CRISPR/Cas system.
(a) Schematic representation of gRNA:Tyrc targeting of the mutant allele (Tyrc) of albino F344 rats and gRNA:TyrC targeting of the wild-type allele (TyrC) of agouti DA rats. (b) Plasmids expressing Cas9 and allele-specific gRNA transfected into F344-derived rat REFs. Cleavage activity by the Surveyor assay was detected with gRNA:Tyrc and with TALENs targeting Tyrc (as a positive control), but not with gRNA:TyrC. M: DNA marker phiX174-HaeIII digest. (c) In DA-derived REFs, cleavage activity was detected with gRNA:TyrC and with TALENs targeting of Tyrc, but not with gRNA:Tyrc. (d) Sequence analysis of the colonies picked from subcloned PCR products from the cultured REFs (b,c). The allele-specific gRNA, and gRNA:Tyrc and gRNA:TyrC showed allele-specific cleavage activity in F344 and DA REFs, respectively, but the TALENs did not act in an allele-specific manner. Data represent the mean±s.d., n=3. *P<0.005 by Student’s t-test. (e) Picture of gRNA:Tyrc-injected (F344 × DA)F1 and (F344 × DA)F1 rats showing the Agouti coat-colour. (f) Some of the gRNA:TyrC-injected F1 rats had albino coloured coats (white arrow) or mosaic coloured coats (grey arrow). (g) Sequence analysis for each of the gRNA-injected F1 hybrid rats. gRNA:Tyrc modified only the F344-allele (Tyrc), while gRNA:TyrC modified only the DA-allele (TyrC) in the F1 hybrid rats. Data represent the mean±s.d., n=3. *P<0.001 by Student’s t-test.
Figure 3
Figure 3. Recovery of three distinct coat-colour mutations by CRISPR/Cas.
(a) Schematic illustration of three coat-colour mutations in rats. albino (Tyrc): SNP missense mutation in the Tyr gene. non-agouti (Asipa): 19-bp deletion in exon 2 of the Agouti signalling protein (Asip) gene. hooded (Kith): integration of an 7,098-bp endogenous retrovirus (ERV) element within the first intron of the Kit gene. (b) Coat-colour phenotypes (C, a, h) recovered from albino by injecting gRNA:Tyrc, Cas9 mRNA, and ssODN of the TyrC allele into F344 rat embryos (c, a, h). (c) Sequence analysis of the targeted Tyr exon 2 in the injected F344 rats. Cas9 and gRNA with ssODN mediated the introduction of several indel mutations, and the precise HDR-mediated SNP exchange of TyrC. (d) Recovery of the non-agouti phenotype by injecting gRNA:Asipa, Cas9 mRNA, and ssODN of the AsipA allele into F344 rat embryos. Cas9 and gRNA with ssODN mediated the introduction of several indel mutations, and the precise short DNA fragment integration of the AsipA gene. (e) Recovery of the hooded mutation by injecting gRNA:Kith-1, gRNA:Kith-2, and ssODN of the KitH allele into F344 rat embryos. Cas9 and two gRNAs with ssODN mediated the introduction of indel mutations at the targeted Kith-1 locus, and the precise large deletion between the two cutting edges of KitH. (f) PCR analysis of the injected F344 rats using primers designed against each outer side of the two LTR sequences. M: DNA marker phiX174-HaeIII digest.

References

    1. Yamori Y. Overview: studies on spontaneous hypertension-development from animal models toward man. Clin. Exp. Hypertens. A 13, 631–644 (1991). - PubMed
    1. Chappel C. I. & Chappel W. R. The discovery and development of the BB rat colony: an animal model of spontaneous diabetes mellitus. Metabolism 32, 8–10 (1983). - PubMed
    1. Serikawa T. & Yamada J. Epileptic seizures in rats homozygous for two mutations, zitter and tremor. J. Hered. 77, 441–444 (1986). - PubMed
    1. Jacob H. J. & Kwitek A. E. Rat genetics: attaching physiology and pharmacology to the genome. Nat. Rev. Genet. 3, 33–42 (2002). - PubMed
    1. Aitman T. J. et al. Progress and prospects in rat genetics: a community view. Nat. Genet. 40, 516–522 (2008). - PubMed

Publication types

Substances